Prevention of HLA alloimmunization by using leukocyte-depleted components.
Andreu
G
G
Poste de Transfusion Sanguine, Hôtel-Dieu de Paris, France.
Dewailly
J
J
D000818:Animals; D016913:Blood Component Transfusion / Q000009:adverse effects*; D006680:HLA Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000097:blood; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D007958:Leukocyte Count; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I; D007518:Isoantibodies